Bleak session for FTSE

FTSE investors suffered a bleak session today as heavyweight mining stocks and drug maker AstraZeneca dragged the London market into the red.

Bleak session for FTSE

FTSE investors suffered a bleak session today as heavyweight mining stocks and drug maker AstraZeneca dragged the London market into the red.

AstraZeneca shares were down more than 4% after it lost a key patent for its best-selling heartburn treatment Nexium.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited